Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
Fiona MarraElise J SmoldersOmar El-SherifAlison BoyleKatherine DavidsonAndrew J SommervilleCatia MarzoliniMarco SiccardiDavid BurgerSara GibbonsSaye KhooDavid BackPublished in: Drugs in R&D (2020)
Dosing of drugs used to treat COVID-19 in patients with renal or hepatic impairment is complex. These recommendations were produced to provide guidance to clinicians worldwide who are treating patients with COVID-19, many of whom will have some degree of acute or chronic renal or hepatic impairment.